EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Clinical trial NCT07262619 · RECRUITING

Trial details

NCT number: NCT07262619
Sponsor: Eikon Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors MSI-H or dMMR Advanced Solid Tumors MSI-H/dMMR Gastric Cancer MSI-H/dMMR Colorectal Cancer MSI-H/dMMR Gastroesophageal-junction Cancer Endometrial Cancer Mismatch Repair Deficient or MSI-High Solid Tumors

Start date: 2026-01-20
Primary completion: 2029-03-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.